PROTAGONIST THERAPEUTICS INC

Ticker: PTGX CUSIP: 74366E102 Class: Common Stock

Bellevue Group AG's Holding History (CIK: 0001674546)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 16,543 Value ($000) $1,445 Avg Close $81.85 Range $62.24 - $96.54
Q3 2025
Shares 20,581 Value ($000) $1,367 Avg Close $56.84 Range $49.38 - $68.26
Q2 2025
Shares 19,472 Value ($000) $1,076 Avg Close $47.99 Range $39.60 - $57.70
Q1 2025
Shares 17,622 Value ($000) $852 Avg Close $41.90 Range $33.70 - $60.60
Q4 2024
Shares 23,718 Value ($000) $916 Avg Close $43.60 Range $33.31 - $48.89
Q3 2024
Shares 12,346 Value ($000) $556 Avg Close $40.40 Range $32.50 - $48.00
Q2 2024
Shares 15,146 Value ($000) $525 Avg Close $29.29 Range $24.22 - $35.96
Q1 2024
Shares 19,146 Value ($000) $554 Avg Close $27.21 Range $21.43 - $33.34
Q4 2023
Shares 30,000 Value ($000) $688 Avg Close $17.50 Range $13.72 - $23.88
Q3 2023
Shares 30,000 Value ($000) $500 Avg Close $19.40 Range $16.33 - $26.81